AU2003283326A8 - Method for identifying compounds which inhibit mechanotransduction in neurons - Google Patents
Method for identifying compounds which inhibit mechanotransduction in neuronsInfo
- Publication number
- AU2003283326A8 AU2003283326A8 AU2003283326A AU2003283326A AU2003283326A8 AU 2003283326 A8 AU2003283326 A8 AU 2003283326A8 AU 2003283326 A AU2003283326 A AU 2003283326A AU 2003283326 A AU2003283326 A AU 2003283326A AU 2003283326 A8 AU2003283326 A8 AU 2003283326A8
- Authority
- AU
- Australia
- Prior art keywords
- mechanotransduction
- neurons
- inhibit
- identifying compounds
- identifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 210000002569 neuron Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42209802P | 2002-10-30 | 2002-10-30 | |
| EP02024474.5 | 2002-10-30 | ||
| US60/422,098 | 2002-10-30 | ||
| EP02024474 | 2002-10-30 | ||
| PCT/EP2003/012084 WO2004040299A2 (en) | 2002-10-30 | 2003-10-30 | Method for identifying compounds which inhibit mechanotransduction in neurons |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003283326A8 true AU2003283326A8 (en) | 2004-05-25 |
| AU2003283326A1 AU2003283326A1 (en) | 2004-05-25 |
Family
ID=56290498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003283326A Abandoned AU2003283326A1 (en) | 2002-10-30 | 2003-10-30 | Method for identifying compounds which inhibit mechanotransduction in neurons |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1556693A2 (en) |
| AU (1) | AU2003283326A1 (en) |
| WO (1) | WO2004040299A2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19850015A1 (en) * | 1998-10-30 | 2000-05-04 | Max Delbrueck Centrum | Proteins of the stomatin family and their use as target proteins for ore therapy |
| WO2003060093A2 (en) * | 2002-01-10 | 2003-07-24 | The Trustees Of Columbia University In The City Of New York | METHODS AND COMPOSITIONS FOR PROPAGATING VECTORS CONTAINING TOXIC cDNAs AND ION CHANNEL ASSAY SYSTEMS |
-
2003
- 2003-10-30 WO PCT/EP2003/012084 patent/WO2004040299A2/en not_active Ceased
- 2003-10-30 AU AU2003283326A patent/AU2003283326A1/en not_active Abandoned
- 2003-10-30 EP EP03775263A patent/EP1556693A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004040299A2 (en) | 2004-05-13 |
| WO2004040299A3 (en) | 2004-07-15 |
| EP1556693A2 (en) | 2005-07-27 |
| AU2003283326A1 (en) | 2004-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1655036T3 (en) | Method for treating oncological diseases | |
| IL181922A0 (en) | Method for treating vasculitis | |
| GB0316089D0 (en) | Differentiation method | |
| IL164352A0 (en) | Methods for treating tweak-related conditions | |
| AU2003272713A8 (en) | A method for treating severe tinnitus | |
| IL175818A0 (en) | Method for treating adamts-5- associated disease | |
| AU2003304722A1 (en) | Method for treating waste-activated sludge using elecroporation | |
| GB0301972D0 (en) | Method for identifying novel treatments | |
| EP1732394A4 (en) | Method for dehydro-roasting | |
| AU2003256995A8 (en) | Method for identifying cancer risk | |
| AU2003237573A8 (en) | Method for wagering | |
| AU2003261957A8 (en) | Method for separating substances | |
| GB0314980D0 (en) | Methods for identifying compounds | |
| EP1486757A4 (en) | Method for displacing controlled objects | |
| AU2003283326A8 (en) | Method for identifying compounds which inhibit mechanotransduction in neurons | |
| AU2003233330A8 (en) | Method for quantifying molecules | |
| AU2003253813A8 (en) | Method for colpoplasty | |
| IL176294A0 (en) | Method for treating metal-containing solutions | |
| ZA200604078B (en) | Method and system for periodontal charting | |
| GB2394492B (en) | Method for enhancing well productivity | |
| EG24296A (en) | Method for lubricating milling material | |
| GB0304215D0 (en) | Method for treating waste | |
| AU2003214103A8 (en) | Method for identifying specific rna-inhibitors | |
| ZA200605875B (en) | Method for identifying people | |
| AU2003249239A8 (en) | Method for selectively inhibiting fungal growth |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |